Detalhe da pesquisa
1.
COVID-19 in a Patient with ß-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
Hemoglobin
; 44(3): 218-220, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552139
2.
Mortality in ß-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
Blood
; 139(13): 2080-2083, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986266
3.
Tricuspid-valve regurgitant jet velocity as a risk factor for death in ß-thalassemia.
Haematologica
; 107(7): 1714-1718, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236055
4.
Prevalence and risk factors for pulmonary arterial hypertension in a large group of ß-thalassemia patients using right heart catheterization: a Webthal study.
Circulation
; 129(3): 338-45, 2014 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081970
5.
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study.
Eur J Echocardiogr
; 12(3): 242-6, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21278193
6.
Human immunodeficiency virus and beta-thalassemia major: A "competition of guilt" for pulmonary arterial hypertension. Report of a case and a review of the literature.
Hemoglobin
; 34(1): 61-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20113290
7.
Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.
Haematologica
; 99(2): e17-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497563
8.
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited.
Intern Emerg Med
; 14(3): 365-370, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948832
9.
Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
Haematologica
; 90(4): 452-8, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15820939
10.
Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
Ann N Y Acad Sci
; 1054: 471-5, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16339700
11.
Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy.
Clin Case Rep
; 3(11): 952-4, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26576280
12.
Typical manifestation of acute congestive heart failure in patients with Thalassaemia major causing diagnostic delay in the emergency room.
Eur J Heart Fail
; 5(5): 607-8, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14607198
13.
Guideline recommendations for heart complications in thalassemia major.
J Cardiovasc Med (Hagerstown)
; 9(5): 515-25, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18404006
14.
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients.
Hemoglobin
; 32(1-2): 97-107, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18274987
15.
Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with thalassemia major: a long-term follow-up study.
Echocardiography
; 22(3): 239-44, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15725159
16.
Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension.
Blood
; 100(4): 1516-7, 2002 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12184280